-
1
-
-
84867790961
-
Primary CNS lymphoma: A clinician's guide
-
10.1586/ern.12.120 23082736 10.1586/ern.12.120
-
Schafer N, Glas M, Herrlinger U (2012) Primary CNS lymphoma: a clinician's guide. Expert Rev Neurother 12(10):1197-1206. doi: 10.1586/ern.12.120
-
(2012)
Expert Rev Neurother
, vol.12
, Issue.10
, pp. 1197-1206
-
-
Schafer, N.1
Glas, M.2
Herrlinger, U.3
-
2
-
-
84866925399
-
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center
-
10.1093/neuonc/nos207 1:CAS:528:DC%2BC38XhsVGqu7vK 3452344 22952196 10.1093/neuonc/nos207
-
Welch MR, Omuro A, Deangelis LM (2012) Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center. Neuro Oncol 14(10):1304-1311. doi: 10.1093/neuonc/nos207
-
(2012)
Neuro Oncol
, vol.14
, Issue.10
, pp. 1304-1311
-
-
Welch, M.R.1
Omuro, A.2
Deangelis, L.M.3
-
3
-
-
84856247948
-
Cognitive functions in primary CNS lymphoma after single or combined modality regimens
-
10.1093/neuonc/nor186 1:CAS:528:DC%2BC38XjsVCnt74%3D 3245999 22013168 10.1093/neuonc/nor186
-
Correa DD, Shi W, Abrey LE, Deangelis LM, Omuro AM, Deutsch MB, Thaler HT (2012) Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro Oncol 14(1):101-108. doi: 10.1093/neuonc/nor186
-
(2012)
Neuro Oncol
, vol.14
, Issue.1
, pp. 101-108
-
-
Correa, D.D.1
Shi, W.2
Abrey, L.E.3
Deangelis, L.M.4
Omuro, A.M.5
Deutsch, M.B.6
Thaler, H.T.7
-
4
-
-
84869188024
-
Surgery for primary CNS lymphoma? Challenging a paradigm
-
10.1093/neuonc/nos159 3499010 22984018 10.1093/neuonc/nos159
-
Weller M, Martus P, Roth P, Thiel E, Korfel A (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14(12):1481-1484. doi: 10.1093/neuonc/nos159
-
(2012)
Neuro Oncol
, vol.14
, Issue.12
, pp. 1481-1484
-
-
Weller, M.1
Martus, P.2
Roth, P.3
Thiel, E.4
Korfel, A.5
-
5
-
-
84869153201
-
Resection of PCNSL, if safely possible, seems to be better than biopsy: Challenging a paradigm?
-
10.1093/neuonc/nos293nos293 3499021 23155110 10.1093/neuonc/nos293
-
Nishikawa R (2012) Resection of PCNSL, if safely possible, seems to be better than biopsy: challenging a paradigm? Neuro Oncol 14(12):1423. doi: 10.1093/neuonc/nos293nos293
-
(2012)
Neuro Oncol
, vol.14
, Issue.12
, pp. 1423
-
-
Nishikawa, R.1
-
6
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330 (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
7
-
-
79953103395
-
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
-
10.1182/blood-2010-09-308684 1:CAS:528:DC%2BC3MXktVGqsbk%3D 21200023 10.1182/blood-2010-09-308684
-
Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R, Maghnouj A, Zollner H, Reinacher-Schick A, Schmiegel W, Hahn SA, Schroers R (2011) Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 117(11):3140-3146. doi: 10.1182/blood-2010-09-308684
-
(2011)
Blood
, vol.117
, Issue.11
, pp. 3140-3146
-
-
Baraniskin, A.1
Kuhnhenn, J.2
Schlegel, U.3
Chan, A.4
Deckert, M.5
Gold, R.6
Maghnouj, A.7
Zollner, H.8
Reinacher-Schick, A.9
Schmiegel, W.10
Hahn, S.A.11
Schroers, R.12
-
8
-
-
84862192105
-
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
-
10.1093/neuonc/nos074nos074 1:CAS:528:DC%2BC38Xhtl2hsb7K 3367845 22492962 10.1093/neuonc/nos074
-
Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S, Krichevsky AM (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol 14(6):689-700. doi: 10.1093/neuonc/ nos074nos074
-
(2012)
Neuro Oncol
, vol.14
, Issue.6
, pp. 689-700
-
-
Teplyuk, N.M.1
Mollenhauer, B.2
Gabriely, G.3
Giese, A.4
Kim, E.5
Smolsky, M.6
Kim, R.Y.7
Saria, M.G.8
Pastorino, S.9
Kesari, S.10
Krichevsky, A.M.11
-
9
-
-
84867500546
-
Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma
-
10.1093/neuonc/nos145nos145 1:CAS:528:DC%2BC38Xht1yns7jJ 3424211 22844109 10.1093/neuonc/nos145
-
Ma X, Yoshimoto K, Guan Y, Hata N, Mizoguchi M, Sagata N, Murata H, Kuga D, Amano T, Nakamizo A, Sasaki T (2012) Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro Oncol 14(9):1153-1162. doi: 10.1093/neuonc/nos145nos145
-
(2012)
Neuro Oncol
, vol.14
, Issue.9
, pp. 1153-1162
-
-
Ma, X.1
Yoshimoto, K.2
Guan, Y.3
Hata, N.4
Mizoguchi, M.5
Sagata, N.6
Murata, H.7
Kuga, D.8
Amano, T.9
Nakamizo, A.10
Sasaki, T.11
-
10
-
-
84856250078
-
Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma
-
10.1093/neuonc/nor169 1:CAS:528:DC%2BC38XjsVCnsbY%3D 3245991 21937590 10.1093/neuonc/nor169
-
Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zollner H, Schmiegel W, Hahn S, Schroers R (2012) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncol 14(1):29-33. doi: 10.1093/neuonc/nor169
-
(2012)
Neuro Oncol
, vol.14
, Issue.1
, pp. 29-33
-
-
Baraniskin, A.1
Kuhnhenn, J.2
Schlegel, U.3
Maghnouj, A.4
Zollner, H.5
Schmiegel, W.6
Hahn, S.7
Schroers, R.8
-
11
-
-
84873741459
-
Differentiating primary CNS lymphoma from glioblastoma multiforme: Assessment using arterial spin labeling, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography
-
10.1007/s00234-012-1089-6
-
Yamashita K, Yoshiura T, Hiwatashi A, Togao O, Yoshimoto K, Suzuki SO, Abe K, Kikuchi K, Maruoka Y, Mizoguchi M, Iwaki T, Honda H (2012) Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography. Neuroradiology. doi: 10.1007/s00234-012-1089-6
-
(2012)
Neuroradiology
-
-
Yamashita, K.1
Yoshiura, T.2
Hiwatashi, A.3
Togao, O.4
Yoshimoto, K.5
Suzuki, S.O.6
Abe, K.7
Kikuchi, K.8
Maruoka, Y.9
Mizoguchi, M.10
Iwaki, T.11
Honda, H.12
-
12
-
-
84866047835
-
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
-
10.1007/s11060-012-0908-2 1:CAS:528:DC%2BC38XhtlWlsr%2FF 22729947 10.1007/s11060-012-0908-2
-
Baraniskin A, Kuhnhenn J, Schlegel U, Schmiegel W, Hahn S, Schroers R (2012) MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma. J Neurooncol 109(2):239-244. doi: 10.1007/s11060-012-0908-2
-
(2012)
J Neurooncol
, vol.109
, Issue.2
, pp. 239-244
-
-
Baraniskin, A.1
Kuhnhenn, J.2
Schlegel, U.3
Schmiegel, W.4
Hahn, S.5
Schroers, R.6
|